HomeRTGN • OTCMKTS
RetinalGenix Technologies Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 643.33K | -6.15% |
Net income | -644.29K | 6.14% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -643.31K | 6.15% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 79.09K | 179,647.73% |
Total assets | 88.85K | 39,390.67% |
Total liabilities | 1.94M | 79.47% |
Total equity | -1.85M | — |
Shares outstanding | 18.09M | — |
Price to book | -20.10 | — |
Return on assets | -1,828.98% | — |
Return on capital | 126.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -644.29K | 6.14% |
Cash from operations | -246.93K | -721.23% |
Cash from investing | — | — |
Cash from financing | 239.11K | 674.53% |
Net change in cash | -7.82K | -318.62% |
Free cash flow | -3.33K | 99.56% |
Previous close
$2.01
Year range
$2.01 - $6.36
Market cap
37.23M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2017
Headquarters
Website
